Skip to content
10-K

Annual Report

LA JOLLA PHARMACEUTICAL CO

0001564590-21-011366

← back to feed
Filed
Mar 8, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Feb 8, 2021 27.43M sh
Cost Of Revenue FY 2020 · Dec 31, 2020 $7.82M
Cost Of Revenue FY 2020 · Dec 31, 2019 $2.39M
Capex FY 2020 · Dec 31, 2019 $698K
Operating Cash Flow FY 2020 · Dec 31, 2019 −$84.95M
Cash And Equivalents FY 2020 · Dec 31, 2019 $87.82M
Current Liabilities FY 2020 · Dec 31, 2019 $24.59M
Total Liabilities FY 2020 · Dec 31, 2019 $188.24M
Current Assets FY 2020 · Dec 31, 2019 $97.46M
Total Assets FY 2020 · Dec 31, 2019 $132.25M
Sga Expense FY 2020 · Dec 31, 2019 $45.13M
Rd Expense FY 2020 · Dec 31, 2019 $85.33M
Net Income FY 2020 · Dec 31, 2019 −$116.51M
Operating Income FY 2020 · Dec 31, 2019 −$109.8M
Revenue FY 2020 · Dec 31, 2019 $23.05M
Stockholders Equity FY 2020 · Dec 31, 2018 $35.92M